ANI PHARMACEUTICALS INC financial data

Symbol
ANIP on Nasdaq
Location
Baudette, MN
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 07 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 262% % -25%
Quick Ratio 62% % -24%
Debt-to-equity 198% % 58%
Return On Equity 9.2% %
Return On Assets 3% %

Shares

Label TTM Value / Value Unit Change %
Entity Public Float $1,200,000,000 USD 46%
Common Stock, Value, Issued $3,000 USD 50%
Weighted Average Number of Shares Outstanding, Basic 20,074,000 shares 3.5%
Weighted Average Number of Shares Outstanding, Diluted 21,093,000 shares 8.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $826,880,000 USD 49%
Research and Development Expense $56,049,000 USD 48%
Costs and Expenses $754,932,000 USD 39%
Operating Income (Loss) $71,948,000 USD 516%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $50,550,000 USD
Income Tax Expense (Benefit) $9,979,000 USD
Net Income (Loss) Attributable to Parent $40,571,000 USD
Earnings Per Share, Basic 1.79 USD/shares
Earnings Per Share, Diluted 1.73 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $262,610,000 USD 81%
Accounts Receivable, after Allowance for Credit Loss, Current $252,617,000 USD 29%
Inventory, Net $146,475,000 USD -1.1%
Assets, Current $698,402,000 USD 34%
Deferred Income Tax Assets, Net $71,396,000 USD 5.5%
Property, Plant and Equipment, Net $63,560,000 USD 12%
Operating Lease, Right-of-Use Asset $5,200,000 USD
Intangible Assets, Net (Excluding Goodwill) $499,817,000 USD -12%
Goodwill $62,480,000 USD 3.4%
Other Assets, Noncurrent $12,497,000 USD 9%
Assets $1,408,152,000 USD 9.4%
Accounts Payable, Current $69,795,000 USD 15%
Employee-related Liabilities, Current $33,221,000 USD 12%
Accrued Liabilities, Current $13,951,000 USD -22%
Contract with Customer, Liability, Current $5,000,000 USD
Liabilities, Current $270,555,000 USD 42%
Operating Lease, Liability, Noncurrent $4,393,000 USD 6.9%
Other Liabilities, Noncurrent $11,270,000 USD 62%
Liabilities $902,335,000 USD 5.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax $2,811,000 USD -48%
Retained Earnings (Accumulated Deficit) $50,589,000 USD 44%
Stockholders' Equity Attributable to Parent $505,817,000 USD 25%
Liabilities and Equity $1,408,152,000 USD 9.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $34,991,000 USD 92%
Net Cash Provided by (Used in) Financing Activities $9,906,000 USD 50%
Net Cash Provided by (Used in) Investing Activities $19,846,000 USD -322%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $4,942,000 USD -34%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $262,646,000 USD 81%
Interest Paid, Excluding Capitalized Interest, Operating Activities $8,895,000 USD 12%
Deferred Tax Assets, Valuation Allowance $9,500,000 USD 2275%
Deferred Tax Assets, Gross $120,737,000 USD 18%
Operating Lease, Liability $5,200,000 USD
Payments to Acquire Property, Plant, and Equipment $2,474,000 USD -46%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $38,016,000 USD
Lessee, Operating Lease, Liability, to be Paid $7,214,000 USD 8.3%
Operating Lease, Liability, Current $1,799,000 USD 15%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,779,000 USD 10%
Lessee, Operating Lease, Liability, to be Paid, Year One $2,084,000 USD 5.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.081 pure -0.25%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1,022,000 USD 3.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three $1,793,000 USD 39%
Deferred Tax Assets, Operating Loss Carryforwards $27,254,000 USD 840%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1,666,667 shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $1,024,000 USD -21%
Additional Paid in Capital $586,230,000 USD 15%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $82,600,000 USD 55%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%